cagrilintide retatrutide blend Reta/Cagri – 12.5mg/2.5mg Cagrilintide 10mg, Semaglutide 10mg Blend
Description
Specifically, it produces no IGF-1 elevation (avoiding proliferative concerns), no negative impact on glucose metabolism (avoiding diabetes risk), no fluid retention or edema, and no concerning patterns of joint pain that can occur with growth hormone
Working with a physician and a licensed compounding pharmacy provides quality control and oversight that gray-market sources cannot
Embrace the process, have fun with it, and enjoy the beautiful results
Kerns, C
